Application of population pharmacokinetics to cladribine

BACKGROUND: The nucleoside analog cladribine is used for the treatment of a variety of indolent B- and T-cell lymphoid malignancies. The primary aim of the study was to evaluate the population distribution of pharmacokinetic parameters in patients undergoing treatment with cladribine and to detect t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindemalm, Synnöve, Savic, Radojka M, Karlsson, Mats O, Juliusson, Gunnar, Liliemark, Jan, Albertioni, Freidoun
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079880/
https://www.ncbi.nlm.nih.gov/pubmed/15757511
http://dx.doi.org/10.1186/1471-2210-5-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079880/
https://www.ncbi.nlm.nih.gov/pubmed/15757511
http://dx.doi.org/10.1186/1471-2210-5-4

Ejemplares similares